Zobrazeno 1 - 10
of 83
pro vyhledávání: '"Edvan de queiroz Crusoe"'
Autor:
Marcia Garnica, Edvan De Queiroz Crusoe, Glaciano Ribeiro, Rosane Bittencourt, Roberto José Pessoa Magalhães, Karla Richter Zanella, Abrahão Elias Hallack Neto, Juliana Souza Lima, Caroline Bonamin Solo, Emmanuella Graciott Souza, Andre Magalhaes Fernandes, Angelo Maiolino, Vania Hungria
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss 2, Pp 153-160 (2024)
Introduction: This study evaluated outcomes and risk factors for COVID-19 in 91 Brazilian multiple myeloma (MM) patients between April 2020 and January 2022. Results: Of the 91 MM patients diagnosed with COVID-19, 64% had comorbidities and 66% requir
Externí odkaz:
https://doaj.org/article/c9edf6eb43b64924bc1b945f53f5c868
Autor:
Maricy Almeida Viol Ferreira Lopes, Fabiana Higashi, Edvan de Queiroz Crusoe, Ana Lucia Miguel Peres, Priscilla Cury, Vania Tietsche de Moraes Hungria
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss 2, Pp 259-265 (2023)
Introduction: Multiple myeloma is characterized by proliferation of clonal plasma cells. The identification of prognostics factors to identify patient's risk is important. Among the studied factors, it was identified of relevant importance the lactic
Externí odkaz:
https://doaj.org/article/cfef73e5e75d4719aa1a19709599ec9f
Autor:
Edvan de Queiroz Crusoe, Abrahão Elias Hallack Neto, Deise Ferreira Nantes, Eduardo Flavio Oliveira Ribeiro, Fernando Monteiro Correia Pinto, Jaisson Andre Pagnoncelli Bortolini, James Farley Rafael Maciel, Jose Francisco Comenalli Marques Junior, Lorena Costa Corrêa, Marcelo Eduardo Zanella Capra, Maria do Perpétuo Socorro Sampaio Carvalho, Nelcivone Soares de Melo, Rafaela Vasques de Oliveira Quintas, Thiago Xavier Carneiro, Violete Petitto Laforga, Renato Luiz Guerino Cunha
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 45, Iss 4, Pp 417-418 (2023)
Externí odkaz:
https://doaj.org/article/01f015e0020b472b98f248cdae960f4b
Autor:
Edvan De Queiroz Crusoe, Fabiana Higashi, Gracia Martinez, Rosane Bittencourt, Jorge Vaz Pinto Neto, Lais Sousa, Rodrigo Santucci, Roberto José Pessoa Magalhães, Gilberto Colli, Renata Ferreira Marques Nunes, Glaciano Ribeiro, Jandir Nicacio, Karla Richter Zanella, Jose Mauro Kutner, Andre Magalhaes, Danielle Leao, Abrahão Elias Hallack Neto, Walter Braga, Emanuella G Souza, Antonio Julio A.M. Guimaraes, Giovanna Steffenello Durigon, Dani Laks, Angelo Maiolino, Vania Tietsche de Moraes Hungria
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 42, Iss 2, Pp 118-124 (2020)
Background: The treatment of multiple myeloma (MM) has evolved significantly in the past decade, and new drug combinations have improved the response rates and prolonged survival. Studies comparing different induction chemotherapy regimens have shown
Externí odkaz:
https://doaj.org/article/dd8ebf2a8a304f048bea1d07e647aa46
Autor:
Angelo Maiolino, Luciano J. Costa, Marcelo Pasquini, Edvan de Queiroz Crusoe, Afonso Celso Vigorito, Marco Aurélio Salvino, Fernanda Salles Seguro, Jayr Schmidt Filho, Vania Tietsche de Moraes Hungria
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 43, Iss , Pp S30-S34 (2021)
Extraordinary progress has been made over the last decade in the treatment of multiple myeloma with the incorporation of new drugs, particularly proteasome inhibitors, immunomodulators, and monoclonal antibodies.The combined use of innovative drugs,
Externí odkaz:
https://doaj.org/article/6b4eb551c30a469fa37f117d2387670c
Autor:
Thais Rodrigues da Cunha Fischer, Fabiana Higashi, Edvan de Queiroz Crusoe, Vania Tietsche de Moraes Hungria
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 38, Iss 2, Pp 166-169 (2016)
Externí odkaz:
https://doaj.org/article/aeee676a13934919a9f9d60c2f51b4e2
Autor:
Edvan de Queiroz Crusoe, Fabiana Higashi, Maria Paula Nalesso Camargo Padilha, Eliana Cristina Martins Miranda, Adriana Alvares Quero, Manuella de Souza Sampaio Almeida, Ana Lucia M. Peres, Priscilla Cury, Carlos Chiattone, Jose Carlos Barros, Vania Tietsche de Moraes Hungria
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 36, Iss 1, Pp 19-24 (2014)
Background: Induction therapy followed by high-dose chemotherapy and autologous transplantation is the standard treatment for suitable patients with multiple myeloma. Objective: The aim of this study was to assess whether induction therapy with thali
Externí odkaz:
https://doaj.org/article/00490626cf084f76809b5e5b1ae827b8
Autor:
Vania Tietsche de Moraes Hungria, Edvan de Queiroz Crusoe, Adriana Alvarez Quero, Manuella Sampaio, Angelo Maiolino, Wanderley Marques Bernardo
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 35, Iss 3, Pp 201-217 (2013)
Externí odkaz:
https://doaj.org/article/26382d23d5ff44e6ab3a017911a9736a
Autor:
Edvan de Queiroz Crusoe, Fabiana Higashi, Gracia Aparecida Martinez, José Carlos Barros, Marcelo Bellesso, Marina Rossato, Ana Cinira F. Marret, Carlos Sérgio Chiattone, Vania Tietsch de Moraes Hungria
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 38, Iss 4, Pp 302-309
ABSTRACT Background: Cyclophosphamide plus thalidomide as induction for multiple myeloma patients eligible for autologous stem cell transplantation may be a limiting factor for cell mobilization. The minimum acceptable mobilized peripheral blood stem
Externí odkaz:
https://doaj.org/article/e1b9cfae18ed4946b29fe8e6a1b26587
Autor:
Luiza Soares Vieira da Silva, Edvan de Queiroz Crusoe, Lais Rocha Guimarães de Souza, Carlos Sérgio Chiattone, Vânia Tietsche de Moraes Hungria
Publikováno v:
Revista Brasileira de Hematologia e Hemoterapia, Vol 39, Iss 4, Pp 331-336
Abstract Background: The emergence of oligoclonal bands, proteins differing from those originally identified at diagnosis, has been reported in multiple myeloma patients after high-dose chemotherapy followed by autologous stem cell transplantation an
Externí odkaz:
https://doaj.org/article/faa2ae3e013f4402b97cb658b6bb5d85